Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-29
DOI
10.3389/fimmu.2022.835997
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Nonaspirin nonsteroidal anti‐inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory‐wide study
- (2021) Bofei Li et al. CANCER
- The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
- (2021) Manlio Tolomeo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TNFα promotes oral cancer growth, pain, and Schwann cell activation
- (2021) Elizabeth Salvo et al. Scientific Reports
- Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
- (2021) Tianxia Lan et al. Cells
- Helicobacter pylori Subdues Cytokine Signaling to Alter Mucosal Inflammation via Hypermethylation of Suppressor of Cytokine Signaling 1 Gene During Gastric Carcinogenesis
- (2021) Iqra Jan et al. Frontiers in Oncology
- Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis
- (2021) Mayara Martina Abatti Chiamulera et al. BMC CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Understanding and treating the inflammatory adverse events of cancer immunotherapy
- (2021) Michael Dougan et al. CELL
- Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review
- (2021) Uzdan Uz et al. Clinical and Experimental Otorhinolaryngology
- Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
- (2021) Stefan Schreiber et al. GASTROENTEROLOGY
- TNF in the era of immune checkpoint inhibitors: friend or foe?
- (2021) Allen Y. Chen et al. Nature Reviews Rheumatology
- Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
- (2021) Alhadi Almangush et al. Frontiers in Oncology
- Transforming targeted cancer therapy with PROTACs: A forward-looking perspective
- (2021) William Farnaby et al. CURRENT OPINION IN PHARMACOLOGY
- PROTAC-Mediated Degradation of Janus Kinase as a Therapeutic Strategy for Cancer and Rheumatoid Arthritis
- (2021) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
- (2021) Keisuke Taniguchi et al. Scientific Reports
- PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
- (2021) Si-Min Qi et al. Frontiers in Pharmacology
- Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia
- (2021) Yunchao Chang et al. BLOOD
- Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
- (2021) Zhenyi Hu et al. CHEMBIOCHEM
- Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review
- (2021) Tamara Diesch et al. CYTOKINE
- Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review
- (2021) Elena Ferrari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SD‐36 promotes growth inhibition and induces apoptosis via suppression of Mcl‐1 in glioma
- (2021) Shiqi Kong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Protein degradation technology: a strategic paradigm shift in drug discovery
- (2021) Haobin Li et al. Journal of Hematology & Oncology
- TF-PROTACs Enable Targeted Degradation of Transcription Factors
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
- (2021) Areeg Elmusrati et al. International Journal of Oral Science
- NF-κB and Pancreatic Cancer; Chapter and Verse
- (2021) John Silke et al. Cancers
- Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
- (2021) Tong Xie et al. Frontiers in Oncology
- The Role of Tumor Necrosis Factor-α (TNF-α) Polymorphisms in Gastric Cancer: a Meta-Analysis
- (2021) Maryam Gholamalizadeh et al. Journal of Gastrointestinal Cancer
- TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain
- (2021) Moses M. Kasembeli et al. BIOCHEMICAL PHARMACOLOGY
- Development of photocontrolled BRD4 PROTACs for tongue squamous cell carcinoma (TSCC)
- (2021) Zhenzhen Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy
- (2021) Garrett Anderson et al. Cancers
- Hi-JAK-ing the ubiquitin system: The design and physicochemical optimisation of JAK PROTACs
- (2020) Rishi R. Shah et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A randomized, phase 1, placebo‐controlled trial of APG‐157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor‐associated microbes
- (2020) Saroj K. Basak et al. CANCER
- Antitumor activity of a novel oral STAT3 inhibitor YHO‐1701
- (2020) Fukiko Nishisaka et al. CANCER SCIENCE
- Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness
- (2020) Hannah S. Hong et al. International Journal of Oral Science
- Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
- (2020) Wook Jin Cells
- Future Therapeutic Directions for Smac-Mimetics
- (2020) Emma Morrish et al. Cells
- Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs
- (2020) Rosanna Marsella et al. VETERINARY DERMATOLOGY
- Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
- (2020) Xiao-Yun Zhao et al. Cells
- The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues
- (2020) Joshua D. Webster et al. Frontiers in Cell and Developmental Biology
- Targeting Estrogen Receptor α for degradation with PROTACs: A Promising Approach to Overcome Endocrine Resistance
- (2020) Xin Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of STAT1 to Promote Gastric Tumorigenesis in Mice
- (2020) Jun T. Low et al. GASTROENTEROLOGY
- Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
- (2020) Yonghan He et al. Journal of Hematology & Oncology
- Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
- (2020) Xu-Shan Sun et al. LANCET ONCOLOGY
- Loss of NF‐kB1 and c‐Rel accelerates oral carcinogenesis in mice
- (2020) Yanhong Ni et al. ORAL DISEASES
- Oral squamous cell carcinoma diagnosed from saliva metabolic profiling
- (2020) Xiaowei Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
- (2020) Riley D. Metcalfe et al. Frontiers in Immunology
- STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
- (2020) Milad Ashrafizadeh et al. Biology-Basel
- LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
- (2020) J. Bourhis et al. ANNALS OF ONCOLOGY
- Itacitinib (INCB039110), a JAK1 inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-Cell Therapy
- (2020) Eduardo Huarte et al. CLINICAL CANCER RESEARCH
- Targeting STAT3 in Cancer Immunotherapy
- (2020) Sailan Zou et al. Molecular Cancer
- Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides
- (2020) Jamie V. Shiah et al. MOLECULAR CANCER THERAPEUTICS
- JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
- (2020) Sairaj Satarker et al. POSTGRADUATE MEDICINE
- Head and neck squamous cell carcinoma
- (2020) Daniel E. Johnson et al. Nature Reviews Disease Primers
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antagonism of IAPs enhances CAR T cell efficacy
- (2019) Jessica Michie et al. Cancer Immunology Research
- The role of regulatory T cells in the response to radiation therapy in head and neck cancer
- (2019) Ayman J Oweida et al. JNCI-Journal of the National Cancer Institute
- Targeting Interleukin-6 Signaling in Clinic
- (2019) Sujin Kang et al. IMMUNITY
- The IRX-2 regimen combined with nivolumab in recurrent/metastatic solid tumors: A phase 1b study to evaluate the safety, determine recommended phase 2 dose (RP2D), and investigate the biologic and clinical activity.
- (2019) Rohit K. Jain et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus
- (2019) Christopher G. Németh et al. PLoS One
- The relationship between TNF-α gene promoter polymorphism (− 1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer
- (2019) Radosław Mlak et al. SUPPORTIVE CARE IN CANCER
- Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
- (2019) Gillian A. Durham et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
- (2019) Jatin Sharma et al. Frontiers in Pharmacology
- The JAK/STAT Pathway in Skeletal Muscle Pathophysiology
- (2019) Viviana Moresi et al. Frontiers in Physiology
- Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
- (2019) David W. Vredevoogd et al. CELL
- Emerging roles for Interleukin-11 in disease
- (2019) Paul M. Nguyen et al. GROWTH FACTORS
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway
- (2019) Yujia Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical update on head and neck cancer: molecular biology and ongoing challenges
- (2019) Elham Alsahafi et al. Cell Death & Disease
- Structural and functional consequences of the STAT5BN642H driver mutation
- (2019) Elvin D. de Araujo et al. Nature Communications
- TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
- (2019) Harald Wajant et al. Frontiers in Cell and Developmental Biology
- Targeting cytokines to treat autoimmunity
- (2019) Vasileios C. Kyttaris CLINICAL IMMUNOLOGY
- Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions
- (2019) Anca Negovan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
- (2019) Katherine A. Hutcheson et al. JAMA Otolaryngology-Head & Neck Surgery
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- Inhibit versus Destroy: Are PROTAC Degraders the Solution to Targeting STAT3?
- (2019) Lisa N. Heppler et al. CANCER CELL
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- Anti-TNF, a magic bullet in cancer immunotherapy?
- (2019) Anne Montfort et al. Journal for ImmunoTherapy of Cancer
- Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
- (2019) Haibin Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
- (2019) Katie L. Owen et al. Cancers
- Potentially Malignant Oral Disorders and Cancer Transformation
- (2018) DIVYA GANESH et al. ANTICANCER RESEARCH
- Mutations in the signal transducer and activator of transcription family of genes in cancer
- (2018) Nahid Shahmarvand et al. CANCER SCIENCE
- The regulation of JAKs in cytokine signaling and its breakdown in disease
- (2018) Henrik M. Hammarén et al. CYTOKINE
- Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner
- (2018) Lorraine A. O’Reilly et al. IMMUNITY
- Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
- (2018) Jacopo Sgrignani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
- (2018) Riccardo Dolcetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
- (2018) Yu Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The plasma levels of 12 cytokines and growth factors in patients with gastric cancer
- (2018) Zhengyun Zou et al. MEDICINE
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
- (2018) Anthony Tolcher et al. ONCOLOGIST
- Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
- (2018) Jenny D. Beebe et al. PHARMACOLOGY & THERAPEUTICS
- IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers
- (2018) Gregory T Wolf et al. OncoTargets and Therapy
- The molecular basis of JAK/STAT inhibition by SOCS1
- (2018) Nicholas P. D. Liau et al. Nature Communications
- Oral inflammation promotes oral squamous cell carcinoma invasion
- (2018) Cameron Goertzen et al. Oncotarget
- Review: Cell Death, Nucleic Acids, and Immunity
- (2018) Keith B. Elkon Arthritis & Rheumatology
- Relationship Between Tumor Necrosis Factor-α rs361525 Polymorphism and Gastric Cancer Risk: A Meta-Analysis
- (2018) Tianshu Xu et al. Frontiers in Physiology
- Gastric cancer: epidemiology, prevention, classification, and treatment
- (2018) Robert Sitarz et al. Cancer Management and Research
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The BRIGHTER trial: A phase 3 randomized double-blind study of napabucasin (NAPA) plus paclitaxel (PTX) versus placebo (PBO) plus PTX in patients (pts) with pretreated advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma.
- (2018) Manish A. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular details of cytokine signalling via the JAK/STAT pathway
- (2018) Rhiannon Morris et al. PROTEIN SCIENCE
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- NFKB1 and Cancer: Friend or Foe?
- (2018) Julia Concetti et al. Cells
- “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
- (2018) Emira Bousoik et al. Frontiers in Oncology
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Immunotherapy in advanced gastric cancer, is it the future?
- (2018) C. Coutzac et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
- (2018) Matthew J. Reilley et al. Journal for ImmunoTherapy of Cancer
- Effects of potentially functional polymorphisms in suppressor of cytokine signaling 3 (SOCS3 ) on the risk of head and neck squamous cancer
- (2017) Dong Hang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition
- (2017) Bernd Groner et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation
- (2017) Nicole N. Scheff et al. PAIN
- Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray
- (2017) Xiaoqiang Quan et al. Oncology Letters
- Salivary and serum levels of tumor necrosis factor-alpha in oral lichen planus: a systematic review and meta-analysis study
- (2017) Hamid Reza Mozaffari et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
- (2017) Ping Li et al. Frontiers in Pharmacology
- Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment
- (2017) Mengmeng Jiang et al. Frontiers in Immunology
- Identification of novel small molecules that inhibit STAT3-dependent transcription and function
- (2017) Iryna Kolosenko et al. PLoS One
- IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
- (2017) Ji Wook Moon et al. Scientific Reports
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells
- (2016) Kuo-Chu Lai et al. CANCER LETTERS
- The role of IL-11 in immunity and cancer
- (2016) Dixon H. Xu et al. CANCER LETTERS
- JAK-STAT signaling in cancer: From cytokines to non-coding genome
- (2016) Jan Pencik et al. CYTOKINE
- Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators
- (2016) Steve Oghumu et al. INTERNATIONAL JOURNAL OF CANCER
- Oral cancer: Etiology and risk factors: A review
- (2016) Malay Kumar et al. Journal of Cancer Research and Therapeutics
- Mouse models for gastric cancer: Matching models to biological questions
- (2016) Ashleigh R Poh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases
- (2016) Tiziana Lorenzini et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Overexpression of Bcl-2, SOCS 1, 3 and Cdh 1, 2 are associated with the early neoplasic changes in modified 4-nitroquinoline 1-oxide-induced murine oral cancer model
- (2016) Adriana Alicia Cabrera Ortega et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model
- (2016) Alison K. Bauer et al. MOLECULAR CARCINOGENESIS
- IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma
- (2016) Hsuan-Yu Peng et al. Molecular Oncology
- The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations
- (2016) Jessica L. Geiger et al. ORAL ONCOLOGY
- Transcriptomic characterization of differential gene expression in oral squamous cell carcinoma: a meta-analysis of publicly available microarray data sets
- (2016) Yang Sun et al. TUMOR BIOLOGY
- Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
- (2016) Uddalak Bharadwaj et al. Oncotarget
- CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
- (2016) Sabari Vallath et al. Scientific Reports
- The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer
- (2016) Guanli Huang et al. Scientific Reports
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment
- (2015) Kazumasa Mori et al. BMC CANCER
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFN That Induce PD-L1 Expression in Head and Neck Cancer
- (2015) F. Concha-Benavente et al. CANCER RESEARCH
- Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
- (2015) Michinori Ogura et al. CANCER SCIENCE
- Pathogenesis of myeloproliferative neoplasms
- (2015) Radek C. Skoda et al. EXPERIMENTAL HEMATOLOGY
- Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins
- (2015) Edmond M. Linossi et al. IMMUNOLOGICAL REVIEWS
- IL-11 signaling as a therapeutic target for cancer
- (2015) Tracy L Putoczki et al. Immunotherapy
- The JAK/STAT signaling cascade in gastric carcinoma (Review)
- (2015) PUJA KHANNA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Chemopreventive Activity of Systemically Administered Curcumin on Oral Cancer in the 4-Nitroquinoline 1-Oxide Model
- (2015) Vinícius de Paiva Gonçalves et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells
- (2015) N. C. Schmitt et al. MOLECULAR CANCER THERAPEUTICS
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
- (2015) N D Peyser et al. ONCOGENE
- Targeting JAK kinase in solid tumors: emerging opportunities and challenges
- (2015) M Buchert et al. ONCOGENE
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas
- (2015) P. S. Hammerman et al. Cancer Discovery
- Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
- (2015) Do-Youn Oh et al. Cancer Research and Treatment
- JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth
- (2015) Malabika Sen et al. NEOPLASIA
- Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
- (2015) Malgorzata Szelag et al. PLoS One
- The molecular regulation of Janus kinase (JAK) activation
- (2014) Jeffrey J. Babon et al. BIOCHEMICAL JOURNAL
- Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy
- (2014) Annamaria Ruzzo et al. BMC CANCER
- IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling
- (2014) H Fukui et al. BRITISH JOURNAL OF CANCER
- Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors
- (2014) Johanna C. Bendell et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Surprising Cross-Species Conservation in the Genomic Landscape of Mouse and Human Oral Cancer Identifies a Transcriptional Signature Predicting Metastatic Disease
- (2014) M. D. Onken et al. CLINICAL CANCER RESEARCH
- A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2014) E. Angevin et al. CLINICAL CANCER RESEARCH
- Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234
- (2014) Paul M. Harari et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of Jak/STAT Signaling in Immunity and Disease
- (2014) Alejandro V. Villarino et al. JOURNAL OF IMMUNOLOGY
- Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies
- (2014) Stephen M. Condon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Survival Patterns in Squamous Cell Carcinoma of the Head and Neck: Pain as an Independent Prognostic Factor for Survival
- (2014) Cielito C. Reyes-Gibby et al. JOURNAL OF PAIN
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase
- (2014) Yibing Shan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- Epithelial gp130/Stat3 functions: An intestinal signaling node in health and disease
- (2014) Matthias Ernst et al. SEMINARS IN IMMUNOLOGY
- Association of interleukin 22 polymorphisms with gastric cancer risk
- (2014) Shan-yu Qin et al. TUMOR BIOLOGY
- Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing
- (2014) Swee Seong Wong et al. Nature Communications
- Chronic Inflammation and Cytokines in the Tumor Microenvironment
- (2014) Glauben Landskron et al. Journal of Immunology Research
- Immune Modulation in Cancer with Antibodies
- (2013) David B. Page et al. Annual Review of Medicine
- Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
- (2013) Tracy L. Putoczki et al. CANCER CELL
- OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
- (2013) Mi-Jung Kim et al. CANCER LETTERS
- STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model
- (2013) L. Couronne et al. HAEMATOLOGICA
- TNF-α signalling and inflammation: interactions between old acquaintances
- (2013) Hana Zelová et al. INFLAMMATION RESEARCH
- Phosphorylated Signal Transducer and Activator of Transcription-1 Immunohistochemical Expression Is Associated With Improved Survival in Patients With Oral Squamous Cell Carcinoma
- (2013) Elena Pappa et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition
- (2013) Nadia J Kershaw et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells
- (2013) H Oshima et al. ONCOGENE
- AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
- (2013) E. R. Plimack et al. ONCOLOGIST
- Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes
- (2013) Vonn Walter et al. PLoS One
- Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
- (2013) Yunbao Pan et al. PLoS One
- Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications
- (2013) Zhengguang Wang et al. PLoS One
- A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases
- (2013) F Hayakawa et al. Blood Cancer Journal
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Targeting STAT3 in gastric cancer
- (2012) Andrew S Giraud et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma
- (2012) L Liu et al. GENE THERAPY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- JAK/STAT signaling in hematological malignancies
- (2012) W Vainchenker et al. ONCOGENE
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- Stat3: Linking inflammation to (gastrointestinal) tumourigenesis
- (2011) Matthias Ernst et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Randomised phase II study of siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in combination with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
- (2011) K. Fizazi et al. EUROPEAN JOURNAL OF CANCER
- TNFR1-induced activation of the classical NF-κB pathway
- (2011) Harald Wajant et al. FEBS Journal
- Smac Mimetics Activate the E3 Ligase Activity of cIAP1 Protein by Promoting RING Domain Dimerization
- (2011) Rebecca Feltham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of SOCS1-/- Lethal Autoinflammatory Disease Correlated to Enhanced Peripheral Foxp3+ Regulatory T Cell Homeostasis
- (2011) E. L. Collins et al. JOURNAL OF IMMUNOLOGY
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Association of −308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma
- (2011) Gefter Thiago Batista Corrêa et al. ORAL ONCOLOGY
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
- (2011) N. Agrawal et al. SCIENCE
- Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
- (2011) E. C. Dueber et al. SCIENCE
- Understanding Carcinogenesis for Fighting Oral Cancer
- (2011) Takuji Tanaka et al. Journal of Oncology
- Janus kinase 3 missense mutation in a child with jacobsen syndrome
- (2010) Douglas R. Lotz et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- The role of Stat5 transcription factors as tumor suppressors or oncogenes
- (2010) G. Ferbeyre et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
- (2010) C. Nielsen et al. HAEMATOLOGICA
- Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells
- (2010) Jacqueline A. Gasche et al. INTERNATIONAL JOURNAL OF CANCER
- Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell Carcinoma
- (2010) Shailaja K. Rao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer
- (2010) Mitsushige Sugimoto WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor necrosis factor and cancer, buddies or foes?
- (2009) Xia Wang et al. ACTA PHARMACOLOGICA SINICA
- Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma: The Multiethnic Cohort Study
- (2009) M. Epplein et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer
- (2009) L. Vitale-Cross et al. Cancer Prevention Research
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Prognostic significance of molecular markers in oral squamous cell carcinoma: A multivariate analysis
- (2009) Neelam G. Shah et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- STAT3 as a prognostic marker in human gastric cancer
- (2009) Cameron B Jackson et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Cytokine and cytokine receptor gene polymorphisms and their functionality
- (2008) Andrew J.P. Smith et al. CYTOKINE & GROWTH FACTOR REVIEWS
- STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
- (2008) Matthias Ernst et al. JOURNAL OF CLINICAL INVESTIGATION
- Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
- (2008) Mitchell Machtay et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3 expression in gastric cancer indicates a poor prognosis
- (2008) Dae-Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- JAKandMPLmutations in myeloid malignancies
- (2008) Ayalew Tefferi LEUKEMIA & LYMPHOMA
- Genetic association of cytokine DNA polymorphisms with head and neck cancer
- (2008) Zoe Serefoglou et al. ORAL ONCOLOGY
- SOCS regulation of the JAK/STAT signalling pathway
- (2008) Ben A. Croker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started